Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Adoption of Lean Principles in a High-Volume Molecular Diagnostic Microbiology Laboratory
Mitchell, P. Shawn, Mandrekar, Jayawant N. , Yao, Joseph D. , Yao, Joseph D C

Journal of Clinical Microbiology | May 15, 2014 | Volume: 52 | Issue: 7 | Pages: 2689-2693

10.1128/jcm.00430-14 | PMID 24829247 Get It

ABSTRACT Clinical laboratories are constantly facing challenges to do more with less, enhance quality, improve test turnaround time, and reduce operational expenses. Experience with adopting and applying lean concepts and tools used extensively in the manufacturing industry is described for a high-volume clinical molecular microbiology laboratory, illustrating how operational success and benefits can be achieved.
Faster Replication and Higher Expression Levels of Viral Glycoproteins Give the Vesicular Stomatitis Virus/Measles Virus Hybrid VSV-FH a Growth Advantage over Measles Virus
Ayala-Bretón, Camilo, Russell, Luke, Russell, Stephen J. , Peng, Kah-Whye , Russell, Luke O J, Russell, Stephen J

Journal of Virology | May 15, 2014 | Volume: 88 | Issue: 15 | Pages: 8332-8339

10.1128/jvi.03823-13 | PMID 24829351 Get It

ABSTRACT VSV-FH is a hybrid vesicular stomatitis virus (VSV) with a deletion of its G glycoprotein and encoding the measles virus (MV) fusion (F) and hemagglutinin (H) envelope glycoproteins. VSV-FH infects cells expressing MV receptors and is fusogenic and effective against myeloma xenografts in mice. We evaluated the fusogenic activities of MV and VSV-FH in relationship to the density of receptor on the target cell surface and the kinetics of F and H expression in infected cells. Using a panel of cells expressing increasing numbers of the MV receptor CD46, we evaluated syncytium size in MV- or VSV-FH-infected cells. VSV-FH is not fusogenic at low CD46 density but requires less CD46 for syncytium formation than MV. The size of each syncytium is larger in VSV-FH-infected cells at a specific CD46 density. While syncytium size reached a plateau and did not increase further in MV-infected CHO cells expressing ≥4,620 CD46 copies/cell, there was a corresponding increase in syncytium size with increases in CD46 levels in VSV-FH-infected CD46-expressing CHO (CHO-CD46) cells. Further analysis in VSV-FH-infected cell lines shows earlier and higher expression of F and H mRNAs and protein. However, VSV-FH cytotoxic activity was reduced by pretreatment of the cells with type I interferon. In contrast, the cytopathic effects are not affected in MV-infected cells. In summary, VSV-FH has significant advantages over MV as an oncolytic virus due to its higher viral yield, faster replication kinetics, and larger fusogenic capabilities but should be used in cancer types with defective interferon signaling pathways. IMPORTANCE We studied the cytotoxic activity of a vesicular stomatitis/measles hybrid virus (VSV-FH), which is superior to that of measles virus (MV), in different cancer cell lines. We determined that viral RNA and protein were produced faster and in higher quantities in VSV-FH-infected cells. This resulted in the formation of larger syncytia, higher production of infectious particles, and a more potent cytopathic effect in permissive cells. Importantly, VSV-FH, similar to MV, can discriminate between low- and high-expressing CD46 cells, a phenotype important for cancer therapy as the virus will be able to preferentially infect cancer cells that overexpress CD46 over low-CD46-expressing normal cells.
Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a Lung Transplant Patient
Khare, Reeti , Gupta, Sounak , Arif, Sana , Jentoft, Mark E. , Deziel, Paul J. , Roden, Anja C. , Wilhelm, Mark , Wengenack, Nancy L. , Wilhelm, Mark P, Razonable, Raymund R.

Journal of Clinical Microbiology | May 14, 2014 | Volume: 52 | Issue: 7 | Pages: 2722-2725

10.1128/jcm.00216-14 | PMID 24829237 Get It

ABSTRACT We present a case of disseminated Neosartorya pseudofischeri infection in a bilateral lung transplant patient with cystic fibrosis. The organism was originally misidentified from respiratory specimens as Aspergillus fumigatus using colonial and microscopic morphology. DNA sequencing subsequently identified the organism correctly as N. pseudofischeri .
Hepatic Uterus-Like Mass Misdiagnosed as Hepatic Abscess
Sopha, Sabrina C., Rosado, Flavia, Smith, J. Joshua , Merchant, Nipun B. , Shi, Chanjuan , Rosado, Flavia G N, Smith, J Joshua

International Journal of Surgical Pathology | May 14, 2014 | Volume: 23 | Issue: 2 | Pages: 134-139

10.1177/1066896914534465 | PMID 24827588 Get It

Background. Hepatic endometriosis/uterus-like mass is rare and may be overlooked during hepatic cyst workups. We report a case of uterus-like mass, misdiagnosed as hepatic abscess. Case Report: A 47-year-old woman developed abdominal pain and vomiting. Infectious colitis with hepatic abscess was diagnosed, and remained antibiotic-refractory. Fine-needle aspiration and core biopsies showed benign contents. The patient presented to our institution with symptoms and normal blood work. Laparoscopic excision demonstrated a 1.4-cm cyst composed of endometrial glands (estrogen receptor+ and progesterone receptor+) and stroma (CD10+) with smooth muscle actin (SMA+), arranged in an organoid fashion. The patient, status-post hysterectomy, had no history or symptoms of endometriosis. Conclusion. This rare case illustrates the merit of considering uterus-like mass/endometriosis in the differential diagnosis of antibiotic-refractory hepatic cysts. Cyst heterogeneity may confound needle biopsy. We report the first instance of a hepatic uterus-like mass, with a review of related entities, postulated histogenesis, and important clinical associations.
Process Mapping and RFID
Clark, David Allen, Pasupathy, Kalyan S.

Encyclopedia of Business Analytics and Optimization | May 14, 2014 | Volume: No volume available | Issue: No issue available | Pages: 1898-1909

10.4018/978-1-4666-5202-6.ch170 Get It

Healthcare processes have variability embedded within care delivery systems. Process mapping has been traditionally used to study processes, and is based on human perceptions of how the process is structured and how care is delivered. Process mapping can be biased based on individual perceptions and not comprehensive to capture variability. Radio frequency identification (RFID) provides a more objective means for collecting process-related data. This paper discusses process mapping, its benefits and drawbacks, and how RFID can complement process mapping. Qualitative information (process mapping) and quantitative information (data collected using RFID and from other sources) can potentially be combined to develop process models. Such models can inform process improvement and increase safety and efficiency.
Increasing Visibility through Process Mining
Clark, David Allen, Pasupathy, Kalyan S.

Encyclopedia of Business Analytics and Optimization | May 14, 2014 | Volume: No volume available | Issue: No issue available | Pages: 1192-1202

10.4018/978-1-4666-5202-6.ch110 Get It

Healthcare processes have variability embedded within care delivery systems. Healthcare providers and managers need visibility of the process to understand variability, and make process design changes, to improve safety and efficiency. Process mapping has been traditionally used to study processes, and is based on perceptions. However, to better understand and manage variability, there is an urgent need for process mining techniques. Process mining requires data for validation, to increase understanding and/or change perceptions and improve visibility. Radio frequency identification (RFID) can be used for collecting process-related data and can eliminate data quality issues. This paper discusses process mining and its application in healthcare, summarizes process mapping and RFID, and proposes an integration framework and method to improve visibility.
Does the addition of a nerve wrap to a motor nerve repair affect motor outcomes?
Parisi, Thomas J., Friedrich, Patricia F. , Shin, Alexander Y. , Lee, Joo‐Yup , Bishop, Allen T. , Shin, Alexander Y

Microsurgery | May 14, 2014 | Volume: 34 | Issue: 7 | Pages: 562-567

10.1002/micr.22274 | PMID 24828470 Get It

The purpose of this study was to evaluate the effect of wrapping bioabsorbable nerve conduit around primary suture repair on motor nerve regeneration in a rat model. Forty rats were randomly divided into two experimental groups according to the type of repair of the rat sciatic nerve: group I had primary suture repair; group II had primary suture repair and bioabsorbable collagen nerve conduit (NeuraGen® 1.5 mm, Integra LifeSciences Corp., Plainsboro, NJ) wrapped around the repair. At 12 weeks, no significant differences in the percentage of recovery between the two groups were observed with respect to compound muscle action potentials, isometric muscle force, and muscle weight (P = 0.816, P = 0.698, P = 0.861, respectively). Histomorphometric analysis as compared to the non‐operative sites was also not significantly different between the two groups in terms of number of myelinated axons, myelinated fiber area, and nerve fiber density (P = 0.368, P = 0.968, P = 0.071, respectively). Perineural scar tissue formation was greater in primary suture repair group (0.36 ± 0.15) than in primary repair plus conduit wrapping group (0.17 ± 0.08). This difference was statistically significant (P < 0.001). Wrapping bioabsorbable nerve conduit around primary nerve repair can decrease perineural scar tissue formation. Although the scar‐decreasing effect of bioabsorbable nerve wrap does not translate into better motor nerve recovery in this study, it might have an effect on the functional outcome in humans where scar formation is much more evident than in rats. © 2014 Wiley Periodicals, Inc. Microsurgery 34:562–567, 2014.
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: An analysis of the SYNTAX Study
Bourantas, Christos V. , Zhang, Yao‐Jun , Garg, Scot , Mack, Michael J. , Dawkins, Keith D., Mohr, Friedrich W., Colombo, Antonio , Holmes, David R. , Ståhle, Elisabeth , Feldman, Ted , Morice, Marie‐Claude, Vries, Ton de, Morel, Marie‐Angèle , Kappetein, A. Pieter , Serruys, Patrick W. , Garg, Scot

Catheterization and Cardiovascular Interventions | May 14, 2014 | Volume: 85 | Issue: 2 | Pages: 199-206

10.1002/ccd.25545 | PMID 24824456 Get It

ObjectivesTo investigate the prognostic implications of the presence of severe lesion calcification in patients undergoing coronary artery bypass graft (CABG) operation.BackgroundThere is robust evidence that lesion calcification is a predictor of worse prognosis in patients undergoing percutaneous coronary intervention; however, there is limited data about the prognostic implication of lesion calcium in patients treated with CABG.MethodsWe retrospectively analyzed data from 1,545 patients who underwent CABG and were recruited in the SYNTAX study and CABG registry. Two experts reviewed the angiographic data and classified patients in two groups: those with severely calcified coronary arteries and those without severe lesion calcification. Clinical outcomes at 5‐year follow‐up were collected and compared in the two groups.ResultsOne out of three patients exhibited severe lesion calcification (n = 588). Patients with calcified coronaries had an increased mortality at 5‐year follow‐up (17.1% vs. 9.9%, P < 0.001) and a higher event rate of death‐myocardial infarction (MI) compared with those without (19.4% vs. 13.2%, P = 0.003), but there was no statistical significant difference between the two groups for major adverse cardiovascular events (MACE, 26.8% vs. 21.8%, P = 0.057). In multivariate Cox regression analysis severe lesion calcification was an independent predictor of an increased all‐cause mortality (hazard ratio: 1.39, 95% confidence interval: 1.02–1.89; P = 0.037) but it was not an independent predictor of the combined end‐points death‐MI or MACE.ConclusionsSevere lesion calcification is associated with an increased mortality in patients undergoing CABG, but it is not an independent predictor of death‐MI or MACE. This paradox can be attributed to the fact that CABG allows perfusion of the healthy coronaries bypassing the diseased arteries and thus it minimizes the risk of coronary events due to progressive atherosclerosis. © 2014 Wiley Periodicals, Inc.
The utility of restaging bone marrow biopsy in PET‐negative patients with diffuse large B‐cell lymphoma and baseline bone marrow involvement
Jackson, Amie E., Smeltzer, Jacob P., Jones, Jason M. , Burnette, Brian L., Ristow, Kay M., Wiseman, Gregory A., Macon, William R. , Nowakowski, Grzegorz S. , Habermann, Thomas M. , Witzig, Thomas E.

American Journal of Hematology | May 14, 2014 | Volume: 89 | Issue: 9 | Pages: 865-867

10.1002/ajh.23760 | PMID 24823914 Get It

Patients with diffuse large B‐cell lymphoma (DLBCL) and pre‐treatment bone marrow (BM) involvement require a restaging BM biopsy to document complete remission (CR). We investigated whether BM assessment by restaging PET‐CT could obviate the need for a repeat BM biopsy. Patients with DLBCL and a positive BM biopsy at diagnosis were identified from the Mayo Clinic Lymphoma Data Base. The concordance of BM status on restaging histopathology and PET‐CT reports and the positive (PPV) and negative predictive value (NPV) of PET‐CT were determined. One thousand eighty patients with DLBCL were evaluated and 69 patients (6%) had DLBCL involving the BM at diagnosis. Of 46 patients who completed frontline chemoimmunotherapy, 34 had a restaging PET‐CT and BM biopsy and were included in the analysis. Thirty‐three patients had a negative BM by both PET‐CT and BM biopsy; one patient had persistent BM involvement by biopsy and PET‐CT. Thus, restaging PET‐CT had 100% PPV and 100% NPV for assessing residual BM disease. The findings were validated in a prospective cohort of 68 DLBCL patients treated on a phase II clinical trial where four patients (6%) had DLBCL involving the BM at diagnosis. All had a negative BM by both restaging BM biopsy and PET‐CT. Compared with the gold standard of BM biopsy, PET‐CT had a 100% NPV to exclude residual BM disease after frontline therapy. If further validated, DLBCL practice guidelines and response criteria could be modified so that BM biopsy is no longer required to document CR if the restaging PET‐CT is negative. Am. J. Hematol. 89:865–867, 2014. © 2014 Wiley Periodicals, Inc.
Impact of Sociodemographic Patient Characteristics on the Efficacy of Decision Aids
Coylewright, Megan , Inselman, Jonathan , Shah, Nilay D. , Montori, Víctor M. , Ting, Henry H. , Branda, Megan, Inselman, Jonathan W, Shah, Nilay , Hess, Erik, LeBlanc, Annie , Branda, Megan E. , Hess, Erik P. , Montori, Victor M

Circulation: Cardiovascular Quality and Outcomes | May 14, 2014 | Volume: 7 | Issue: 3 | Pages: 360-367

10.1161/hcq.0000000000000006 | PMID 24823953 Get It

Background— Decision aids (DAs) increase patient knowledge, reduce decisional conflict, and promote shared decision making (SDM). The extent to which they do so across diverse sociodemographic patient groups is unknown. Methods and Results— We conducted a patient-level meta-analysis of 7 randomized trials of DA versus usual care comprising 771 encounters between patients and clinicians discussing treatment options for chest pain, myocardial infarction, diabetes mellitus, and osteoporosis. Using a random effects model, we examined the impact of sociodemographic patient characteristics (age, sex, education, income, and insurance status) on the outcomes of knowledge transfer, decisional conflict, and patient involvement in SDM. Because of small numbers of people of color in the study population, we were not powered to investigate the role of race. Most patients were aged ≥65 years (61%), white (94%), and women (59%); two thirds had greater than a high school education. Compared with usual care, DA patients gained knowledge, were more likely to know their risk, and had less decisional conflict along with greater involvement in SDM. These gains were largely consistent across sociodemographic patient groups, with DAs demonstrating similar efficacy when used with vulnerable patients such as the elderly and those with less income and less formal education. Differences in efficacy were found only in knowledge of risk in 1 subgroup, with greater efficacy among those with higher education (35% versus 18%; P =0.02). Conclusions— In this patient-level meta-analysis of 7 randomized trials, DAs were efficacious across diverse sociodemographic groups as measured by knowledge transfer, decisional conflict, and patient involvement in SDM. To the extent that DAs increase patient knowledge and participation in SDM, they have potential to impact health disparities related to these factors.